Clinical Trial Update: MCG for Suspected INOCA Confirmed by Thermodilution-Derived CFR

View source ↗

Summary

A completed clinical trial evaluating MCG for suspected INOCA, with diagnosis confirmed by thermodilution-derived coronary flow reserve.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Coronary Microvascular Disease
• Ischemic Heart Disease

Snippet

Sponsor: Genetesis Inc. | Conditions: Ischemic Heart Disease, Coronary Microvascular Disease | Status: COMPLETED